623936-76-5

Upstream product

• 623936-79-8 (E)-(4R,5R)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-octadec-2-enoic acid methyl ester 
• 623936-81-2 {(2R,3R)-3-[(1R,2R)-2-(tert-Butyl-dimethyl-silanyloxy)-1-methyl-pentadecyl]-oxiranyl}-methanol 
• 623937-00-8 (2S,3R)-3-Benzyloxy-2-[(S)-2-({(2S,3R)-3-[(1S,2R)-2-((S)-3-benzyloxy-2-tert-butoxycarbonylamino-propionyloxy)-1-methyl-pentadecyl]-oxiranecarbonyl}-amino)-3-methyl-butyrylamino]-butyric acid allyl ester 
• 623936-89-0 (2S,3R)-3-[(1R,2R)-2-(tert-Butyl-dimethyl-silanyloxy)-1-methyl-pentadecyl]-oxirane-2-carboxylic acid allyl ester 
• 623936-80-1 (E)-(4R,5R)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-octadec-2-en-1-ol 
• 623936-91-4 (2S,3R)-3-((1S,2R)-2-Hydroxy-1-methyl-pentadecyl)-oxirane-2-carboxylic acid allyl ester 
• 452956-81-9 (2S,3R)-3-(tert-Butyl-dimethyl-silanyloxy)-2-methyl-hexadecanal 
• 623937-02-0 (2S,3R)-3-Benzyloxy-2-[(S)-2-({(2S,3R)-3-[(1S,2R)-2-((S)-3-benzyloxy-2-tert-butoxycarbonylamino-propionyloxy)-1-methyl-pentadecyl]-oxiranecarbonyl}-amino)-3-methyl-butyrylamino]-butyric acid 
• 623936-96-9 (2S,3R)-3-[(1S,2R)-2-((S)-3-Benzyloxy-2-tert-butoxycarbonylamino-propionyloxy)-1-methyl-pentadecyl]-oxirane-2-carboxylic acid 
• 623936-94-7 (2S,3R)-3-[(1S,2R)-2-((S)-3-Benzyloxy-2-tert-butoxycarbonylamino-propionyloxy)-1-methyl-pentadecyl]-oxirane-2-carboxylic acid allyl ester 

Downstream Products

• 623936-74-3 (1S,4S,7S,10S,13R,14S,15R)-7-((R)-1-Benzyloxy-ethyl)-10-benzyloxymethyl-4-isopropyl-14-methyl-13-tridecyl-12,16-dioxa-3,6,9-triaza-bicyclo[13.1.0]hexadecane-2,5,8,11-tetraone 

Relevant academic research and scientific papers

Towards the synthesis of [15]-membered stevastelins through the 2,3-epoxy analogues

A synthetic approach to the [15]-membered stevastelins, a novel class of immunosuppressant agents, is reported based on a macrolactamization route to the 2,3-epoxy derivative 6. The synthesis of this compound was achieved via a stereoselective epoxidation